Medartis Holding AG
🇨🇭XSWX.MEDSwitzerlandHealthcare
PriceCHF 85.80+1.70 (+2.02%)
Latest anomalies
Negative 2 detected in the last 120 days
- High: 1
- Medium: 1
- Low: 0
Volume: a spike above the 20-day average
12-1M momentum: flipped sign, from positive to negative
Free with a Finzer account.
Profile
- Healthcare
- Medical Devices
- Switzerland
Identity
- Exchange
- SIX Swiss Exchange . XSWX
- Type
- Stock
- ISIN
- CH0386200239
- CUSIP
- Not reported
Company
- Employees
- 1,158
- Headquarters
- Basel, Switzerland
- Website
- https://www.medartis.com
Market
- Shares outstanding
- 12.4M
- Market cap
- CHF 1.07B
Highlights
- Market cap
- CHF 1.07B
- EPS LTM
- -CHF 0.55
- P/E LTM
- -156.67calculatedCalculated by Finzer, not reported by the data provider.
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- CHF 197.7M+13.17%up year on year
- Net income
- -CHF 6.63M-2,651.15%down year on year
- Gross margin
- 78.55%-6.38%down year on year
- Free cash flow
- -CHF 21.91M-298.38%down year on year
Latest news
News is not sourced for this exchange.
Business summary
Medartis Holding AG is a company in the healthcare sector, listed on SIX Swiss Exchange (Switzerland) under the ticker MED. Its market capitalisation is CHF 1.07B, from 12.4M shares outstanding, as of . Across the 249 trading sessions to the shares traded between CHF 70.60 and CHF 97.50, and the last close of CHF 85.80 sits 57% of the way up that range. The company is headquartered in Basel, Switzerland, and employs about 1,158 people. The same company also trades as 1RU on Frankfurt Stock Exchange.
Medartis Holding AG, a medical device company, engages in the development, manufacturing, and sales of implant solutions worldwide. The company's medical devices are used for the treatment of surgical fixation of bone fractures for upper and lower extremities, as well as for the cranio-maxillofacial surgery. It provides osteosynthesis products for the hand, wrist, forearm, elbow, shoulder, and foot and ankle, as well as for the areas of the mandible, midface, orthognathic, and cranium under the APTUS and MODUS names. The company serves the surgeons, hospitals, and medical centers, as well as group purchasing organizations. The company was incorporated in 1997 and is headquartered in Basel, Switzerland.